KALASH DHILLON: Open Payments
NPI 1265142202 · EAST LANSING, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,821 in 74 payments from 29 companies in 2025. Trend: 2023 $84 · 2024 $886 · 2025 $1,821
Food & beverage: $1,821
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $205 |
| Biogen, Inc. | 7 | $172 |
| UCB, Inc. | 9 | $163 |
| Axsome Therapeutics, Inc. | 1 | $118 |
| Genentech USA, Inc. | 4 | $113 |
| Alnylam Pharmaceuticals Inc. | 3 | $91 |
| ARGENX US, INC. | 3 | $81 |
| Vanda Pharmaceuticals Inc. | 3 | $79 |
| Eisai Inc. | 3 | $76 |
| Alexion Pharmaceuticals, Inc. | 3 | $74 |
Products named: QULIPTA, TYSABRI, Symbravo, Fintepla, ONPATTRO, VYVGART HYTRULO, PONVORY, Leqembi.
Industry payments across MI — which companies pay providers there.
